查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830117

HIFU（高強度聚焦超音波）設備市場（按指導、交付模式、技術、產品、應用和最終用戶）—2025-2032 年全球預測

High Intensity Focused Ultrasound Devices Market by Guidance, Delivery Mode, Technology, Product, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，HIFU（高強度聚焦超音波）設備市場規模將成長至 63.5 億美元，複合年成長率為 10.82%。

主要市場統計數據
基準年2024年 27.9億美元
預計2025年 30.9億美元
預測年份：2032年 63.5億美元
複合年成長率（%） 10.82%

高強度聚焦超音波(HIFU) 設備正在從實驗平台轉型為跨多個專業領域、影響深遠的臨床工具。本介紹將透過探討臨床需求、技術成熟度和監管演變之間的相互作用，為當前的生態系統提供一個框架。近年來，非侵入性和微創工作流程已得到驗證，這加速了臨床醫生的興趣，而更多樣化的設備外形規格也拓寬了其應用途徑。這些趨勢與日益複雜的報銷模式交織在一起，早期積極的臨床結果推動著付款人的參與和機構的投資決策。

臨床發展勢頭受到多種因素的推動，包括影像引導的改進、通訊協定的清晰化以及訓練有素的操作人員數量的不斷增加。同時，製造商正在改進設備的人體工學設計、能量傳輸以及與醫院資訊系統的整合，以提高吞吐量和易用性。主要市場的監管機構也在調整應用途徑以適應新型治療方法，這些療法與可靠證據的產生相結合，正在縮短臨床應用的時間。這些因素共同創造了一個充滿活力的環境，其中策略清晰度、營運準備度和證據一致性將決定哪些相關人員將持續受益於該技術的前景。

轉型重塑病患治療路徑、報銷框架、跨領域合作以及聚焦超音波治療的技術格局

聚焦超音波治療領域正在經歷變革時期，這場變革正在改變臨床路徑、競爭格局以及支付者和提供者的期望。引導系統和治療計劃軟體的進步使得治療過程更加可預測且可重複，而這項技術進步正在推動培訓模式和醫院工作流程的後續變革。隨著設備應用的不斷增加，評估不僅要考慮療效，還要考慮吞吐量、總手術成本以及與現有影像處理設備的互通性。

同時，報銷框架正從特定適應症的實驗應用轉向更結構化的路徑，從而改變財務獎勵並鼓勵更大規模的推廣應用。放射科、腫瘤科和外科之間的跨學科合作正在催生混合醫療模式，將聚焦超音波作為手術或全身性治療的輔助或替代手段。商業策略正在透過多樣化的市場化方式應對，這些方式結合了直接的醫院合作、專科診所參與以及擴展的服務範圍。成功的公司將是那些能夠將研發重點與實際臨床需求相結合，並在各種醫療環境中展示營運和經濟價值的公司。

評估 2025 年美國徵收關稅對供應鏈、採購經濟、協作和醫療設備可近性的累積影響

2025年美國關稅的實施，對超音波設備生態系統產生了累積效應，影響了採購經濟性、供應鏈設計和國際合作模式。關稅導致進口零件和組件成本上升，促使設備製造商重新評估其籌資策略，強調供應商多元化，並盡可能進行近岸外包。雖然這些供應鏈調整降低了單一來源中斷的風險，但也帶來了過渡成本，並增加了供應商資格認證和品管的複雜性。

醫院和專科診所的採購團隊已採取措施，加強供應商評估，並明確總擁有成本的計算。對於那些依賴長期跨國製造夥伴關係的公司來說，關稅加速了他們做出在地化組裝和與經銷商重新談判條款的決策。這也對監管和臨床實驗狀況產生了間接影響。營運成本的上升正在推遲患者入組獎勵，並增加了進行多中心試驗的成本，最終影響證據產生的時間表。

最後，關稅促使經營團隊經營團隊制定更嚴謹的情境規劃，在短期利潤保護措施與供應鏈韌性和成本工程的長期投資之間取得平衡。最終結果是，策略重點重新調整，轉向營運敏捷性、供應商風險管理，以及與面臨資本預算緊張的採購相關人員進行清晰的價值溝通。

細分洞察揭示了影像引導、交付模式、技術選擇、產品類型、臨床使用和最終用戶偏好如何影響採用

了解細分市場的細微差別，可以揭示臨床、技術和商業性選擇如何在不同環境下驅動不同的採用模式。本分析考慮了核磁共振引導和超音波引導的影像引導，這兩種引導方式形成了截然不同的臨床工作流程。核磁共振引導的手術能夠提供更出色的軟組織可視化和溫度測量，但成本更高，並且需要專門的設施。另一方面，超音波引導系統允許更廣泛的照護現場應用和程序靈活性。給藥方式根據體外、間質和腔內途徑區分，每種途徑都適用於不同的臨床團隊、基礎設施需求和患者選擇標準。技術選擇也是一個變化的軸心，與熱感消融相比，機械消融具有獨特的機械生物學優勢。

產品形式多樣，從可攜式到固定式，部署意義重大。可攜式系統方便門診和門診病人環境使用，而固定平台則針對高容量醫院設施進行了最佳化，並配備了先進的影像整合技術。肝腫瘤、胰臟腫瘤、攝護腺癌和子宮肌瘤等臨床應用各自有其獨特的證據需求、轉診途徑和報銷考量，因此臨床採用的速度也各不相同。終端使用者細分包括門診手術中心、醫院和專科診所，這些環境的資本購買週期、人員配備模式和預期手術量各不相同。了解這些細分軸如何交叉，可以實現更有針對性的產品開發、證據生成和商業化策略，使技術屬性與臨床和營運實際情況一致。

比較全球各區域的促進因素、基礎設施準備、監管方法、報銷動態和臨床採用模式的區域見解

區域動態在聚焦超音波技術的採用、推廣和報銷方式方面發揮著至關重要的作用。在美洲，領先的卓越中心和相對快速發展的商業支付市場支持了該技術在某些適應症中的早期臨床應用。從早期應用到更廣泛的機構應用的過渡需要臨床負責人和採購決策者之間的合作，而區域報銷環境通常決定了這一過渡的時機。

在歐洲、中東和非洲，監管和報銷格局差異較大，國家層級的決策和多樣化的醫療服務提供模式需要製定區域合作策略。在某些司法管轄區，集中式衛生技術評估流程提高了證據門檻，而在其他司法管轄區，利基報銷途徑則有助於實現有針對性的部署。因此，製造商必須根據各國支付方預期和醫院資金籌措的差異，量身訂做其臨床和經濟性材料。

亞太地區正因基礎設施投資和日益成長的微創手術需求而創造著巨大的商機，但打入市場策略必須考慮到多樣化的管理體制、多樣化的影像實施以及多樣化的醫院採購慣例。任何地區的成功擴張都取決於能否展現清晰的臨床價值、營運相容性以及符合當地醫療保健重點和資源限制的永續服務模式。

產品平臺、戰略夥伴關係關係、生產規模、監管進展和市場進入定位的競爭企業資料

聚焦超音波領域的公司層面動態呈現競爭、合作和策略專業化交織的特徵。領先的研發商正在推行雙重策略：一方面提升核心技術能力，另一方面建立夥伴關係關係，以擴大臨床覆蓋範圍和服務能力。投資通常專注於改進治療計劃軟體、增強影像整合以及降低每次手術的複雜性，從而降低培訓門檻並擴展可用配置。生產規模和品質系統正成為競爭定位的核心，尤其是在設備從早期臨床應用轉向常規醫院運作的情況下。

與學術中心和臨床網路建立策略聯盟仍然是加速證據產生和建立卓越中心的關鍵策略。同時，商業性差異化通常依賴捆綁培訓、維護和成果支援的服務模式，以解決買家對營運風險的擔憂。監管進展和核准被用來獲得市場進入，但公司也強調上市後證據收集和真實世界數據舉措，以支持報銷談判。對於規模較小的創新者來說，與現有經銷商和設備平台合作仍然是一條可行的市場途徑，而規模較大的公司則尋求選擇性收購，以填補技術或地理空白。競爭格局將有利於那些將臨床檢驗與可擴展製造和現實商業化模式相結合的組織。

為產業領導者提供策略建議，以加速臨床應用、最佳化供應鏈、調整報銷方式並優先考慮研發

產業領導者應專注於一系列切實可行的優先事項，將策略意圖與可衡量的成果連結起來。首先，將研發藍圖與臨床工作流程結合，可確保設備功能降低程序複雜性並解決臨床醫師的痛點。投資以使用者為中心的設計和整合影像工作流程通常可以加快醫療機構的採用速度。其次，透過供應商多元化、本地組裝和模組化組件策略來增強供應鏈的韌性，可以減輕關稅的影響並減少前置作業時間的波動。

第三，證據策略應分層次實施。針對特定適應症、展現出顯著療效的臨床項目必須輔以可操作的真實世界證據舉措，以支持報銷討論。門診手術中心、醫院和專科診所都需要明確的定價、培訓和服務套餐，並使其與購買行為相符。最後，與付款人、學術合作夥伴和系統整合商建立策略夥伴關係可以加速市場進入並拓寬轉診網路。透過設定清晰的指標、分配跨職能資源並保持敏捷的管治，能夠將這些優先事項付諸實踐的高階主管將更有能力將技術前景轉化為持續的臨床和商業性影響。

嚴謹的調查方法，解釋原始資料和二手資料、專家訪談、檢驗步驟、細分邏輯和分析技術

本分析所依據的調查方法遵循嚴格的一手和二手資料收集、專家檢驗和透明的細分邏輯。一手資料研究包括與臨床意見領袖、採購專業人員和技術高管進行結構化訪談，以了解該觀點對臨床工作流程、實施障礙和採購重點的看法。二手資料研究利用同行評審文獻、法規核准和公開文件，對臨床結果、設備屬性和路徑演變進行三角測量。

檢驗步驟將訪談洞察與已發表資料最後覆核，而分析方法則將定性主題綜合與結構化細分框架相結合，以得出可行的結論。細分邏輯將影像引導選項、交付模式、技術類別、產品外形規格、臨床用途和最終用戶偏好與觀察到的採用行為和操作限制進行映射。在整個過程中，品管確保假設得到記錄、來源可追溯，並且解釋以經驗證據為基礎。

這種方法平衡了臨床洞察的深度和操作的嚴謹性，相關人員提供了策略決策和後續分析的可靠基礎。

結論：綜合策略要點、新興風險和機遇，以及領導者在聚焦超音波領域應採取的行動

綜上所述，高強度聚焦超音波的前景令人矚目，既有臨床前景，又有操作複雜性，需要採取嚴謹的策略行動。關鍵要點強調了將設備功能與臨床工作流程相結合、展示清晰的以患者為中心的治療結果，以及以對採購和報銷相關人員有意義的方式體現價值的重要性。新興風險包括供應鏈中斷、不同司法管轄區的監管差異，以及需要強力的證據來獲得更廣泛的付款方支持。

當技術屬性能夠減輕官僚負擔、擴大醫療服務範圍，並顯著提升病患體驗和醫療系統效率時，機會將匯聚。能夠整合臨床檢驗、可擴展生產和實用商業化的組織，將有可能獲得最具永續性的優勢。領導者應採取積極主動的立場，投資於供應鏈韌性，根據最終用戶情況調整上市模式，並建立支付方和臨床夥伴關係關係，以支持更廣泛的應用。

最終，明確的策略重點、根據證據執行的能力和營運適應性將決定哪些相關人員能夠成功地將創新轉化為這個不斷發展的治療領域的持續臨床和商業性影響。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 磁振造影引導的高強度聚焦超音波系統 (HIFU) 的出現，使得腫瘤學應用中的精確即時腫瘤消融成為可能
  • 患者療效的改善和更快的康復推動了 HIFU 在非侵入性子宮肌瘤治療中的應用
  • 擴大高強度聚焦超音波在自發性震顫和帕金森氏症等神經系統疾病的應用
  • 整合即時測溫監測解決方案，提升HIFU組織消融手術的安全性和有效性
  • 開發緊湊型可攜式HIFU 設備，以方便門診和農村醫療環境中的照護現場治療
  • 人們對先進的換能器陣列設計的興趣日益濃厚，旨在改善 HIFU 平台的焦點控制和深度穿透
  • 監管部門的核准和不斷演變的報銷框架加速了HIFU在全球主要醫療保健市場的普及
  • 新興通訊協定結合 HIFU 和放射療法，協同作用，標靶治療抗藥性癌症病變
  • 提高超音波影像影像設備的整合度，在 HIFU 治療期間提供引導式視覺化

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章 HIFU（高強度聚焦超音波）設備市場指南

  • MRI 指南
  • 超音波引導

9. HIFU（高強度聚焦超音波）設備市場（依交付模式）

  • 體外
  • 插頁式廣告
  • 腔內

第 10 章 HIFU（高強度聚焦超音波）設備市場（按技術）

  • 機械消融
  • 熱消融
    • 連續波
    • 脈搏波

第 11 章 HIFU（高強度聚焦超音波）設備市場（按產品）

  • 可攜式的
  • 固定式

第 12 章 HIFU（高強度聚焦超音波）設備市場（按應用）

  • 肝臟腫瘤
  • 胰臟腫瘤
  • 攝護腺癌
  • 子宮肌瘤

第 13 章 HIFU（高強度聚焦超音波）設備市場（按最終用戶）

  • 門診手術中心
  • 醫院
  • 專科診所

第14章。按地區分類的HIFU（高強度聚焦超音波）設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 15 章 HIFU（高強度聚焦超音波）設備市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章。按國家分類的HIFU（高強度聚焦超音波）設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Chongqing Haifu Medical Technology Co., Ltd.
    • Insightec Ltd.
    • EDAP TMS SA
    • SonaCare Medical LLC
    • Alpinion Medical Systems Co., Ltd.
    • GE HealthCare Technologies Inc.
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Hitachi, Ltd.
    • THERACLION SA
Product Code: MRR-43539E5D36FD

The High Intensity Focused Ultrasound Devices Market is projected to grow by USD 6.35 billion at a CAGR of 10.82% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.79 billion
Estimated Year [2025] USD 3.09 billion
Forecast Year [2032] USD 6.35 billion
CAGR (%) 10.82%

High intensity focused ultrasound devices have moved from experimental platforms to influential clinical tools across multiple specialties, and this introduction frames the current ecosystem by examining the interplay of clinical need, technological maturity and regulatory evolution. Recent years have seen proof points in noninvasive and minimally invasive workflows that have accelerated clinician interest, while a more diverse set of device form factors has broadened pathways to adoption. These trends intersect with an increasingly complex reimbursement landscape, where early positive clinical outcomes are catalyzing payer engagement and institutional investment decisions.

Clinical momentum is supported by converging drivers: improved imaging guidance, clearer procedural protocols, and a growing cadre of trained operators. Concurrently, manufacturers are refining device ergonomics, energy delivery modalities and integration with hospital information systems to improve throughput and ease of use. Regulatory authorities in key markets have also adapted submission pathways to accommodate novel therapeutic modalities, which reduces time to clinical availability when paired with robust evidence generation. Taken together, these forces create a dynamic environment in which strategic clarity, operational readiness and evidence alignment will determine which stakeholders sustainably benefit from the technology's promise.

Transformations reshaping patient pathways, reimbursement frameworks, cross-disciplinary collaborations, and technological landscape in focused ultrasound therapies

The focused ultrasound landscape is undergoing transformative shifts that are altering clinical pathways, competitive dynamics and the expectations of payers and providers. Advances in guidance systems and treatment planning software are enabling more predictable, reproducible procedures, and this technical progress drives downstream changes in training models and hospital workflows. As adoption increases, devices are being evaluated not only on efficacy but also on throughput, total cost of procedure and interoperability with existing imaging suites.

In parallel, reimbursement frameworks are moving from experimental coverage toward more structured pathways in certain indications, shifting economic incentives and encouraging larger-scale deployments. Cross-disciplinary collaborations between radiology, oncology and surgical specialties are fostering hybrid care models that incorporate focused ultrasound as an adjunct or alternative to surgery or systemic therapy. Commercial strategies are responding with diversified go-to-market approaches that combine direct hospital partnerships, specialty clinic engagement and expanded service offerings. The outcome is a market that is more nuanced: success favors organizations that align R&D priorities with real-world clinical needs and that can demonstrate operational and economic value across a spectrum of care settings.

Assessment of the cumulative consequences of United States tariffs in 2025 on supply chains, procurement economics, collaboration and device accessibility

The introduction of United States tariffs in 2025 has produced cumulative effects across the focused ultrasound device ecosystem by influencing procurement economics, supply chain design and international collaboration patterns. Tariff-induced cost increases on imported components and subassemblies have prompted device manufacturers to re-evaluate sourcing strategies, emphasizing supplier diversification and nearshoring where feasible. These supply chain adaptations reduce exposure to single-source disruptions but also introduce transitional costs and complexity in vendor qualification and quality control.

Procurement teams at hospitals and specialty clinics have responded by tightening vendor evaluations and seeking clearer total-cost-of-ownership calculations, which now must account for tariff-inflated capital and consumable expenses. For companies that relied on long-standing cross-border manufacturing partnerships, tariffs have accelerated decisions to localize assembly or to renegotiate commercial terms with distributors. The regulatory and clinical trial landscape has also felt indirect effects: higher operational costs can slow enrollment incentives or increase the cost of running multi-center studies, which in turn affects evidence generation timelines.

Finally, the tariffs have incentivized more rigorous scenario planning among executives, who are balancing short-term margin protection tactics with longer-term investments in supply chain resilience and cost engineering. The net impact is a re-prioritization of strategic focus toward operational agility, supplier risk management and clearer communication of value to procurement stakeholders facing stretched capital budgets.

Segmentation insights revealing how imaging guidance, delivery mode, technology choice, product type, clinical application and end-user setting affect adoption

A nuanced understanding of segmentation reveals how clinical, technical and commercial choices drive differentiated adoption patterns across settings. This analysis considers imaging guidance across MRI Guided and Ultrasound Guided approaches, which create distinct clinical workflows: MRI-guided procedures offer superior soft-tissue visualization and thermometry yet demand higher capital intensity and specialized suites, while ultrasound-guided systems enable broader point-of-care use and procedural flexibility. Delivery mode is differentiated by Extracorporeal, Interstitial and Intracavitary approaches, and each mode aligns with different clinical teams, infrastructure requirements and patient selection criteria. Technology selection is another axis of variation, with Mechanical Ablation offering distinct mechanobiological effects compared with Thermal Ablation; within thermal approaches, the continuous wave and pulsed wave modalities present divergent safety profiles, energy management characteristics and procedural planning needs.

Product form factors range from Portable to Stationary devices, and that distinction has profound implications for deployment: portable systems facilitate ambulatory and outpatient settings, whereas stationary platforms are optimized for high-volume hospital suites with advanced imaging integration. Clinical applications-spanning Liver Tumor, Pancreatic Tumor, Prostate Cancer and Uterine Fibroids-each have unique evidence requirements, referral pathways and reimbursement considerations, and the pace of clinical adoption varies accordingly. End-user segmentation includes Ambulatory Surgical Centers, Hospitals and Specialty Clinics, and these settings differ in capital purchasing cycles, staffing models and procedural throughput expectations. Understanding how these segmentation axes intersect enables more targeted product development, evidence generation and commercialization strategies that match technology attributes to clinical and operational realities.

Regional insights comparing drivers, infrastructure readiness, regulatory approaches, reimbursement dynamics and clinical adoption patterns across world regions

Regional dynamics play a decisive role in shaping how focused ultrasound technologies are adopted, scaled and reimbursed. In the Americas, leading centers of excellence and a relatively fast-moving private payer market have supported early clinical uptake in selected indications, while robust academic networks have driven multicenter evidence generation. Transitioning from early adopters to broader institutional adoption requires alignment between clinical champions and procurement decision-makers, and the regional reimbursement environment often determines the timing of that transition.

Europe, Middle East & Africa presents a more heterogeneous regulatory and reimbursement landscape, where national-level decision-making and varied healthcare delivery models require localized engagement strategies. In some jurisdictions, centralized health technology assessment processes raise the bar for evidence, while in others niche reimbursement pathways enable targeted deployment. Manufacturers must therefore calibrate clinical and economic dossiers to account for national differences in payer expectations and hospital financing.

Across Asia-Pacific, infrastructure investments and rising demand for minimally invasive treatments are creating sizable opportunities, yet market entry strategies must account for diverse regulatory regimes, varying imaging adoption and differing hospital procurement practices. In all regions, successful expansion hinges on demonstrating clear clinical value, operational fit and sustainable service models that match local healthcare priorities and resource constraints.

Competitive company intelligence on product pipelines, strategic partnerships, manufacturing scale, regulatory progress and go-to-market positioning

Company-level dynamics in the focused ultrasound sector are characterized by a blend of competition, collaboration and strategic specialization. Leading developers are pursuing dual strategies: advancing core technology capabilities while forming partnerships that expand clinical reach and service capacity. Investment focus commonly includes improving treatment planning software, enhancing imaging integration and reducing per-procedure complexity to lower training thresholds and expand usable settings. Manufacturing scale and quality systems are increasingly central to competitive positioning, particularly as devices move from early clinical use into routine hospital operations.

Strategic alliances with academic centers and clinical networks remain a critical tactic for accelerating evidence generation and establishing centers of excellence. At the same time, commercial differentiation often hinges on service models that bundle training, maintenance and outcome support, addressing purchaser concerns about operational risk. Regulatory progress and clearances are leveraged to gain market access, but companies also emphasize post-market evidence collection and real-world data initiatives to support reimbursement conversations. For smaller innovators, partnering with established distributors or device platforms is a pragmatic route to market, while larger firms pursue selective acquisitions to fill technology or geographic gaps. The competitive landscape will favor organizations that integrate clinical validation with scalable manufacturing and pragmatic commercialization models.

Strategic recommendations enabling industry leaders to accelerate clinical adoption, optimize supply chains, align reimbursement approaches and prioritize R&D

Industry leaders should concentrate on a set of actionable priorities that translate strategic intent into measurable outcomes. First, aligning R&D roadmaps with clinical workflows will ensure that device features reduce procedural complexity and address clinician pain points; investments in user-centered design and integrated imaging workflows typically yield faster institutional adoption. Second, strengthening supply chain resilience through supplier diversification, localized assembly and modular component strategies can mitigate tariff exposure and reduce lead-time volatility.

Third, evidence strategies should be tiered: focused, indication-specific clinical programs that demonstrate meaningful patient outcomes must be complemented by pragmatic real-world evidence initiatives to support reimbursement discussions. Fourth, commercial models need to be tailored by end-user; ambulatory surgical centers, hospitals and specialty clinics each require distinct pricing, training and service packages to align with purchasing behaviors. Finally, strategic partnerships with payers, academic collaborators and systems integrators can accelerate market access and broaden referral networks. Executives who operationalize these priorities-by setting clear metrics, allocating cross-functional resources and maintaining agile governance-will be better positioned to convert technological promise into durable clinical and commercial impact.

Rigorous research methodology describing primary and secondary data, expert interviews, validation steps, segmentation logic and analytical techniques

The research methodology underpinning this analysis adheres to rigorous primary and secondary evidence collection, expert validation and transparent segmentation logic. Primary research activities included structured interviews with clinical opinion leaders, procurement professionals and technology executives to capture frontline perspectives on clinical workflows, adoption barriers and purchasing priorities. Secondary research drew on peer-reviewed literature, regulatory clearances and public filings to triangulate clinical outcomes, device characteristics and pathway evolution.

Validation steps incorporated cross-checks between interview insights and published data, while analytical techniques combined qualitative thematic synthesis with structured segmentation frameworks to surface actionable conclusions. The segmentation logic maps imaging guidance options, delivery modes, technological categories, product form factors, clinical applications and end-user settings to observed adoption behaviors and operational constraints. Throughout the process, quality controls ensured that assumptions were documented, sources were traceable and interpretations were anchored to empirical evidence.

This methodological approach balances depth of clinical insight with operational rigor to provide stakeholders a dependable foundation for strategic decisions and follow-on analysis.

Conclusion synthesizing strategic takeaways, emergent risks and opportunities, and actions leaders should pursue to navigate the focused ultrasound landscape

In synthesis, the high intensity focused ultrasound landscape presents a compelling mix of clinical promise and operational complexity that requires disciplined strategic action. Key takeaways emphasize the importance of aligning device capabilities with clinical workflows, demonstrating clear patient-centered outcomes and packaging value in ways that are meaningful to procurement and reimbursement stakeholders. Emergent risks include supply chain disruptions, regulatory variability across jurisdictions and the need for robust evidence to unlock wider payer support.

Opportunities are concentrated where technology attributes reduce procedural burden, expand the settings of care and provide measurable improvements in patient experience or health-system efficiency. Organizations that can integrate clinical validation, scalable manufacturing and pragmatic commercialization will capture the most durable advantage. Leaders should adopt a proactive posture-investing in supply chain resilience, tailoring go-to-market models by end-user setting, and cultivating payer and clinical partnerships that support broader adoption.

Ultimately, clear strategic focus, evidence-aligned execution and operational adaptability will determine which stakeholders successfully convert innovation into sustained clinical and commercial impact in this evolving therapeutic area.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Emergence of MR-guided HIFU systems enabling precise real-time tumor ablation in oncology applications
  • 5.2. Introduction of AI-powered treatment planning software optimizing acoustic beam parameters for personalized HIFU therapy
  • 5.3. Rising adoption of HIFU for noninvasive uterine fibroid treatment driven by improved patient outcomes and faster recovery
  • 5.4. Expansion of high-intensity focused ultrasound applications into neurological disorders such as essential tremor and Parkinson's disease
  • 5.5. Integration of real-time thermometry monitoring solutions to enhance safety and efficacy of HIFU tissue ablation procedures
  • 5.6. Development of compact, portable HIFU devices facilitating point-of-care treatments in outpatient and rural healthcare settings
  • 5.7. Growing focus on advanced transducer array designs improving focal spot control and depth penetration in HIFU platforms
  • 5.8. Regulatory approvals and evolving reimbursement frameworks accelerating HIFU adoption across major global healthcare markets
  • 5.9. Emergence of hybrid HIFU and radiotherapy protocols to synergistically target resistant cancer lesions
  • 5.10. Increasing integration of ultrasound imaging modalities to provide guided visualization during HIFU treatments

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. High Intensity Focused Ultrasound Devices Market, by Guidance

  • 8.1. MRI Guided
  • 8.2. Ultrasound Guided

9. High Intensity Focused Ultrasound Devices Market, by Delivery Mode

  • 9.1. Extracorporeal
  • 9.2. Interstitial
  • 9.3. Intracavitary

10. High Intensity Focused Ultrasound Devices Market, by Technology

  • 10.1. Mechanical Ablation
  • 10.2. Thermal Ablation
    • 10.2.1. Continuous Wave
    • 10.2.2. Pulsed Wave

11. High Intensity Focused Ultrasound Devices Market, by Product

  • 11.1. Portable
  • 11.2. Stationary

12. High Intensity Focused Ultrasound Devices Market, by Application

  • 12.1. Liver Tumor
  • 12.2. Pancreatic Tumor
  • 12.3. Prostate Cancer
  • 12.4. Uterine Fibroids

13. High Intensity Focused Ultrasound Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Specialty Clinics

14. High Intensity Focused Ultrasound Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. High Intensity Focused Ultrasound Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. High Intensity Focused Ultrasound Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Chongqing Haifu Medical Technology Co., Ltd.
    • 17.3.2. Insightec Ltd.
    • 17.3.3. EDAP TMS S.A.
    • 17.3.4. SonaCare Medical LLC
    • 17.3.5. Alpinion Medical Systems Co., Ltd.
    • 17.3.6. GE HealthCare Technologies Inc.
    • 17.3.7. Siemens Healthineers AG
    • 17.3.8. Koninklijke Philips N.V.
    • 17.3.9. Hitachi, Ltd.
    • 17.3.10. THERACLION S. A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY EXTRACORPOREAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTERSTITIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY INTRACAVITARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY MECHANICAL ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PULSED WAVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY LIVER TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PANCREATIC TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY GUIDANCE, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY THERMAL ABLATION, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN HIGH INTENSITY FOCUSED ULTRASOUND DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)